We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
- Authors
Craig, T J; Bewtra, A K; Bahna, S L; Hurewitz, D; Schneider, L C; Levy, R J; Moy, J N; Offenberger, J; Jacobson, K W; Yang, W H; Eidelman, F; Janss, G; Packer, F R; Rojavin, M A; Machnig, T; Keinecke, H-O; Wasserman, R L
- Abstract
The placebo-controlled study International Multicentre Prospective Angioedema C1-INH Trial 1 (I.M.P.A.C.T.1) demonstrated that 20 U/kg C1 esterase inhibitor (C1-INH) concentrate (Berinert®; CSL Behring, Marburg, Germany) is effective in treating acute abdominal and facial Hereditary Angioedema (HAE) attacks.
- Publication
Allergy, 2011, Vol 66, Issue 12, p1604
- ISSN
1398-9995
- Publication type
Journal Article
- DOI
10.1111/j.1398-9995.2011.02702.x